443 results
Page 2 of 23
424B5
qk1aq5fhq ujtfcmcp
30 Jan 24
Prospectus supplement for primary offering
6:05am
UPLOAD
hlpd55w9f k500xb5
21 Dec 23
Letter from SEC
12:00am
8-K
EX-4.1
a8u11f4mkxbjl58 7i9o
30 Nov 23
Seelos Therapeutics Announces Pricing of $5.55 Million Public Offering
4:59pm
8-K
EX-4.2
8mvivxw5xb i4qk
30 Nov 23
Seelos Therapeutics Announces Pricing of $5.55 Million Public Offering
4:59pm
8-K
EX-1.1
z58uma37wb b97o
30 Nov 23
Seelos Therapeutics Announces Pricing of $5.55 Million Public Offering
4:59pm
424B5
z6krh a7o1l
30 Nov 23
Prospectus supplement for primary offering
4:58pm
424B5
s3jffj v0cjgb
28 Nov 23
Prospectus supplement for primary offering
4:06pm
424B3
zf93uh7hpam77hjuav
29 Sep 23
Prospectus supplement
4:56pm
8-K
EX-4.1
ejlz30ljf
25 Sep 23
Entry into a Material Definitive Agreement
4:06pm
8-K
EX-10.1
b1ht5iy8
25 Sep 23
Entry into a Material Definitive Agreement
4:06pm
424B5
lwjd8e975is3ggr
25 Sep 23
Prospectus supplement for primary offering
6:02am
8-K
EX-99.2
aamn7wf8
20 Sep 23
Seelos Therapeutics Announces Top Line Results from SLS-002 Phase II Study in Adults with Major Depressive Disorder at Imminent Risk of Suicide
7:00am
UPLOAD
r6rwnyjhdpkax
20 Sep 23
Letter from SEC
12:00am